Table 3

Number of primary studies and participants for each condition subgroup for the 375 primary studies that registered adverse events, comprising 38 517 participants

Condition subgroupTotal: 375 studies
Number of studies (%)
Total: 38 517 participants
Number of participants (%)
Back pain23 (6.13)2945 (7.65)
Brain injury13 (3.47)1015 (2.64)
Cancer20 (5.33)1607 (4.17)
Cardiovascular53 (14.13)5835 (15.15)
Critical care3 (0.8)554 (1.44)
Diabetes6 (1.60)214 (0.56)
Healthy21 (5.60)3483 (9.04)
HIV3 (0.95)145 (0.41)
Incontinence1 (0.80)257 (0.38)
Musculoskeletal41 (10.93)5077 (13.18)
Neurological33 (8.80)2292 (5.57)
Older Adults99 (26.40)11 467 (29.77)
Osteoporotic6 (1.60)483 (1.25)
Psychiatry15 (4.00)1159 (3.01)
Renal9 (2.40)554 (1.44)
Respiratory29 (7.73)1608 (4.17)